Chicago Cornea enrolling patients in potentially vision-restoring clinical trial

Mar 18, 2012 @ 08:25 PM – by Maria Rosselson

Alongside our colleagues at  the Department of Ophthalmology at Rush University Medical Center, Drs. Randy Epstein and Parag Majmudar are excited to be a part of the Implantable Miniature Telescope (IMT) trial .  We are enrolling patients age 75 and older who have end-stage macular degeneration and cataracts.  The study involves pre-surgery training and assessment, cataract extraction surgery with implantation of an FDA-approved miniature intraocular telescope (IMT) in place of a conventional intraocular lens (IOL) , and post-surgery training with a low-vision specialist.   One eye is operated on and facilitates near vision .  The other eye maintains peripheral vision and together, this "mono-vision" arrangement can allow patients to engage in visual tasks like reading and checkbook balancing.  This is an incredible opportunity to bring a revolutionary technology to those who are good candidates.  Chicago Cornea Consultants continues to be on the leading edge of an innovative, multi-disciplinary approach to management of complex ocular conditions.

Learn more about this trial at: http://www.rush.edu/rumc/page-1298329688895.html

Information about the IMT can also be found at http://www.centrasight.com

Comments (0)

Post Your Comment

Public comments are welcome. All fields are required.